| Literature DB >> 28718697 |
Anna MacDowall1, Yohan Robinson1, Martin Skeppholm2, Claes Olerud1.
Abstract
INTRODUCTION: Pain drawings have been frequently used in the preoperative evaluation of spine patients. For lumbar conditions comprehensive research has established both the reliability and predictive value, but for the cervical spine most of this knowledge is lacking. The aims of this study were to validate pain drawings for the cervical spine, and to investigate the predictive value for treatment outcome of four different evaluation methods.Entities:
Keywords: Cervical spine; Neck Disability Index; outcome; pain drawing; repeatability; surgical treatment
Mesh:
Year: 2017 PMID: 28718697 PMCID: PMC5649326 DOI: 10.1080/03009734.2017.1340372
Source DB: PubMed Journal: Ups J Med Sci ISSN: 0300-9734 Impact factor: 2.384
Demographics at baseline.
| Patient characteristics | Total | |
|---|---|---|
| Age, median (min, max) | 130 | 46 (31, 61) |
| Women/men, | 130 | 67/63 |
| Smokers, | 130 | 39 (30) |
| Non-smokers, | 130 | 91 (70) |
| In work, | 128 | 111 (87) |
| Not in work, | 128 | 17 (13) |
| ΔNDI 2y, median (min, max) | 122 | –22 (–66, 22) |
| ΔNDI 5y, median (min, max) | 115 | –28 (–74, 28) |
NDI: Neck Disability Index; ΔNDI 2y: NDI at 2 years of follow-up minus preoperative NDI; ΔNDI 5y: NDI at 5 years of follow-up minus preoperative NDI.
Principles of dichotomization of the various methods.
| Method | Neurogenic | Non-neurogenic |
|---|---|---|
| Ransford (penalty points) | 0–2 | 3+ |
| Udén | N, PN | NN, PNN |
| Gatchel (ticked boxes, | 0–19 | 20+ |
Percentage pain drawings assessed to each group.
| Method | Percentage of assessedpain drawings |
|---|---|
| Ransford | |
| Neurogenic | 49.6% |
| Non-neurogenic | 50.4% |
| Udén | |
| Neurogenic | 72.1% |
| Non-neurogenic | 27.9% |
| Gatchel | |
| Neurogenic | 44.6% |
| Non-neurogenic | 55.4% |
| Ohnmeiss | |
| Head | |
| 0 | 78.3% |
| 1 | 21.7% |
| Neck | |
| 0 | 20.0% |
| 1 | 80.0% |
| Shoulder | |
| 0 | 4.6% |
| 1 | 95.4% |
| Upper arm | |
| 0 | 9.2% |
| 1 | 90.8% |
| Lower arm | |
| 0 | 3.3% |
| 1 | 96.7% |
| Bilateral | |
| 0 | 75.6% |
| 1 | 24.4% |
Results of the reliability analysis.
| Method | % agreement(all three evaluators) | Light’s κ(all three evaluators) | Cohen’s κ(less very experienced evaluator) | Cohen’s κ(re-evaluation same observer) |
|---|---|---|---|---|
| Ransford | 42 | 0.29 | 0.50 | 0.72 |
| Udén | 61 | 0.36 | 0.43 | 0.50 |
| Gatchel | 85 | 0.79 | 0.80 | 0.88 |
| Ohnmeiss | ||||
| Head | 90 | 0.80 | 0.89 | 0.87 |
| Neck | 91 | 0.81 | 0.78 | 0.91 |
| Shoulder | 98 | 0.88 | 0.90 | 0.82 |
| Upper arm | 95 | 0.81 | 0.89 | 0.95 |
| Lower arm | 100 | 1.00 | 1.00 | 1.00 |
| Bilateral | 93 | 0.88 | 0.86 | 0.98 |
Results from method comparison.
| Method | NDI, preopMean diff. (95% CI) | ΔNDI 2 y (2 y NDI–preop NDI)Mean diff. (95% CI) | ΔNDI 5 y (5 y NDI–preop NDI)Mean diff. (95% CI) |
|---|---|---|---|
| Ransford | 5.4 (2.0, 8.7) 0.0031 | –0.8 (–5.0, 3.5) 0.72 | 0.7 (–4.4, 5.6) 0.78 |
| Udén | 4.2 (0.5, 8.0) 0.031 | 1.9 (–3.6, 7.2) 0.50 | 2.0 (–4.0, 7.7) 0.49 |
| Gatchel | 6.9 (2.4, 11.5) 0.002 | 2.0 (–1.6, 5.7) 0.55 | 3.6 (–3.1, 9.7) 0.27 |
| Ohnmeiss | |||
| Head | 7.5 (2.8, 12.2) 0.002 | –0.5 (–8.4, 7.8) 0.91 | –1.5 (–10.3, 7.5) 0.74 |
| Neck | 5.3 (–1.5, 12.1) 0.12 | 4.1 (–4.1, 12.5) 0.32 | 4.5 (–4.1, 13.4) 0.31 |
| Shoulder | 11.4 (–4.1, 26.3) 0.13 | –13.0 (–18.6, –5.9) < 0.001 | –8.6 (–21.9, 9.3) 0.29 |
| Upper arm | –0.2 (–8.5, 6.9) 0.96 | –10.4 (–18.3, –2.0) 0.014 | –12.1 (–17.4, –6.1) < 0.001 |
| Lower arm | 8.6 (–10.0, 23.8) 0.31 | –2.1 (–11.8, 10.2) 0.72 | 1.7 (–16.4, 12.3) 0.80 |
| Bilateral | 4.1 (–1.2, 9.6) 0.13 | 2.1 (–5.9, 10.0) 0.60 | 3.8 (–4.7, 11.8) 0.37 |
The values are:
The mean difference between preoperative NDI in group N and NN, group 1 and 0.
The mean difference between ΔNDI in group N and group NN, group 1 and group 0.
The mean difference between ΔNDI at the 5-year follow-up, in group N and group NN, group 1 and group 0.
Difference in means presented for each method. The endpoint mean for the N group is subtracted from the endpoint mean in the NN group. For the Ohnmeiss method, the endpoint mean for the group 0 (no markings) was subtracted from the endpoint mean in group 1 (with markings). Hence positive values correspond to larger values on preoperative NDI for the NN group or (for Ohnmeiss) for group 1. For the endpoints representing a change (ΔNDI) this typically means less negative values, i.e. closer to zero, suggesting that the NN group (or group 1) performs ‘worse’.
ΔNDI at 2 years and 5 years postoperative, for all evaluation methods and for the totality of all observers.
| Method | ΔNDI 2 y median(range) | ΔNDI 5 y median(range) |
|---|---|---|
| Ransford | ||
| Neurogenic | –22 (–66, 22) | –30 (–75, 28) |
| Non-neurogenic | –23 (–66, 22) | –28 (–74, 12) |
| Udén | ||
| Neurogenic | –24 (–66, 22) | –30 (–72, 28) |
| Non-neurogenic | –18 (–66, 12) | –22 (–74, 8) |
| Gatchel | ||
| Neurogenic | –22 (–66, 12) | –32 (–70, 28) |
| Non-neurogenic | –24 (–66, 22) | –28 (–74, 12) |
| Ohnmeiss | ||
| Head | ||
| 0 | –22 (–66, 12) | –28 (–74, 28) |
| 1 | –26 (–66, 22) | –30 (–72, 12) |
| Neck | ||
| 0 | –24 (–66, 6) | –31 (–74, 4) |
| 1 | –22 (–66, 22) | –28 (–72, 28) |
| Shoulder | ||
| 0 | –8 (–22, –4) | –16 (–58, 2) |
| 1 | –24 (–66, 22) | –30 (–74, 28) |
| Upper arm | ||
| 0 | –16 (–42, 6) | –16 (–48, –2) |
| 1 | –26 (–66, 22) | –30 (–74, 28) |
| Lower arm | ||
| 0 | –18 (–32, –12) | –36 (–40, –10) |
| 1 | –22 (–66, 22) | –28 (–74, 28) |
| Bilateral | ||
| 0 | –24 (–66, 22) | –30 (–72, 28) |
| 1 | –18 (–66, 12) | –20 (–74, 4) |
Entries are median (min, max).